How to ensure optimal ethical review within the new clinical trials regulation?

Venue: Brussels, Belgium

A revision of the Clinical Trials Regulation has been adopted by European legislation makers. This revised framework will bring significant advances compared to todays’ situation. However, the original objectives of this legislation should be remembered: these were to enhance efficiency of the overall clinical trials authorization process and, in turn, to boost the EU’s competitiveness as a place to conduct research and make for more efficient patients access to new innovative treatments.

More information on www.efgcp.eu